PG
Priyata Goyal
About Priyata Goyal
Data last updated:
Priyata Goyal is a Director at Byrl Bioceuticals India Private Limited (since 2020). The company operates in Healthcare. Byrl Bioceuticals India Private Limited reported revenue of ₹20 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Byrl Bioceuticals India Private Limited U15400DL2020PTC367927 | Director | 13 Aug 2020 | 2020 | ₹20 Lakh (FY 2023) | Active |
Board colleagues of Priyata Goyal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Akanksha Jain | 08067836 | Byrl Bioceuticals India Private Limited | Additional Director |
| Ankur Goyal | 03192139 | Byrl Bioceuticals India Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Priyata Goyal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Priyata Goyal
Priyata Goyal currently holds 1 directorship: Byrl Bioceuticals India Private Limited (Director, since 13 Aug 2020, revenue ₹20 Lakh (FY 2023)).
Priyata Goyal was first appointed on 13 Aug 2020 as Director at Byrl Bioceuticals India Private Limited.
The current boards of Priyata Goyal's companies include Akanksha Jain (Byrl Bioceuticals India Private Limited), Ankur Goyal (Byrl Bioceuticals India Private Limited).